Anti-EZH2 antibody [EPR24902-112]
- 20ul selling size
- Recombinant
- RabMAb
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Knockout Tested Rabbit Recombinant Monoclonal KMT6 / EZH2 antibody. Suitable for WB, I-ELISA and reacts with Human, Mouse, Synthetic peptide samples.
View Alternative Names
KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, Lysine N-methyltransferase 6
- WB
Supplier Data
Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
ab287893 was shown to specifically react with EZH2 (pT345) in untreated Wild-type HAP1, HeLa and NIH/3T3 (Figure A). After treatment with 150 units alkaline phosphatase for 1 hour at 37°C, no band was observed (Figure B). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
EZH2 knockout HAP1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
NIH/3T3 cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 98 kDa,37 kDa
false
- WB
Supplier Data
Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
ab287893 was shown to specifically react with EZH2 (pT345) in HEK-293. The signal was significantly reduced after blocking with 1µg/ml histone-lysine N-methyltransferase EZH2 peptide (pT345). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution
Lane 1:
HEK-293 cell lysate at 20 µg
Lane 2:
HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (unmodified) at 1µg/ml at 20 µg
Lane 3:
HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (pT345) at 1µg/ml at 20 µg
Secondary
Lanes 1 - 3:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 3:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 98 kDa,37 kDa
false
- WB
Supplier Data
Western blot - Anti-EZH2 antibody [EPR24902-112] (AB287893)
ab287893 was shown to specifically react with EZH2 (pT345) in HeLa and NIH/3T3. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-EZH2 antibody [EPR24902-112] (ab287893) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
NIH/3T3 cell lysate at 20 µg
Secondary
Lanes 1 - 2:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 2:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 98 kDa,37 kDa
false
- I-ELISA
Supplier Data
Indirect ELISA - Anti-EZH2 antibody [EPR24902-112] (AB287893)
Indirect ELISA showing the phospho-specificity (pT345) of primary antibody ab287893. Plates were coated with histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 peptide (unmodified) and histone-lysine N-methyltransferase EZH2 peptide (pT487) peptides at 1000 ng/ml. Binding of ab286909 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).
Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EZH2 plays an important role in chromatin remodeling and transcriptional repression through its integration within the PRC2 complex which includes proteins such as SUZ12 and EED. This complex is involved in maintaining the transcriptional silencing of genes essential for development and differentiation. EZH2's activity regulates cell fate decisions and helps preserve stem cell pluripotency through repression of lineage-specific genes.
Pathways
EZH2 integrates into mechanisms often seen in the regulation of the Wnt and Hedgehog signaling pathways. These pathways are central to developmental processes and cell proliferation. In the Wnt pathway EZH2 interacts with proteins such as β-catenin impacting gene expression involved in cell growth. Similarly within the Hedgehog pathway EZH2 may influence gene regulation through its interaction with GLI transcription factors again affecting cellular proliferation and tissue patterning.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com